Report urges more involvement from U.S. health authorities in cannabis policy

As more Americans are using increasingly potent marijuana, a federal advisory panel is recommending a shift towards a public health approach. The report suggests a strategy focused on health, with the CDC playing a more significant role in cannabis policy. Dr. Steven Teutsch of the University of Southern California, who led the committee, emphasized the need for federal leadership in addressing the growing use of marijuana.

Currently, 38 states and the District of Columbia have legalized medical marijuana, with some also allowing recreational use. However, marijuana remains illegal at the federal level, prompting calls for reclassification.

The report highlights the risks associated with heavy marijuana use, especially for teens, pregnant women, and chronic users. Public health concerns have often been overlooked in the rush to legalize cannabis, with industry lobbying influencing policy decisions.

To address these challenges, the report makes several recommendations for the CDC, Congress, and states. These include developing health campaigns, monitoring health impacts, and implementing quality standards for cannabis products.

By embracing federal regulation and prioritizing public health, the report argues that the U.S. can mitigate the risks associated with marijuana use and ensure the well-being of its citizens.